Osaka Medical Center for Cancer and Cardiovascular Diseases
Osaka, 537-8511, Japan
NCT Number: NCT02321865
The objective of this study is to check the dose control method of NPC-02 and the holding effect for the target serum zinc concentration in patients with zinc deficiency.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 3
Osaka, 537-8511, Japan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: approx. 12-24 weeks
Nobelpharma
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07585318
Child Nutrition Disorders, Iron Deficiencies
Guatemala City, Departamento de Guatemala, Guatemala
View Trial DetailsNCT02233764
Iron Deficiencies, Iron Deficiency
Bengaluru, Karnataka, India
View Trial DetailsNCT05085834
Cardiovascular Diseases, Inflammation
Cleveland, Ohio, United States
View Trial DetailsNCT03283813
Body Weight, Glucose Metabolism Disorders
Novara, Italy
View Trial Details